1609341-02-7

Basic information

• Product Name: 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethyl-N-{2-methyl-2-[(2,2,2-trifluoroethyl)amino]propyl}-imidazo[1,2-a]pyridine-3-carboxamide
• Synonyms: 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethyl-N-{2-methyl-2-[(2,2,2-trifluoroethyl)amino]propyl}-imidazo[1,2-a]pyridine-3-carboxamide
• CAS NO: 1609341-02-7
• Molecular Weight: 484.469
• Mol File: 1609341-02-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethyl-N-{2-methyl-2-[(2,2,2-trifluoroethyl)amino]propyl}-imidazo[1,2-a]pyridine-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethyl-N-{2-methyl-2-[(2,2,2-trifluoroethyl)amino]propyl}-imidazo[1,2-a]pyridine-3-carboxamide(1609341-02-7)
• EPA Substance Registry System: 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethyl-N-{2-methyl-2-[(2,2,2-trifluoroethyl)amino]propyl}-imidazo[1,2-a]pyridine-3-carboxamide(1609341-02-7)

Safety Data

• Hazardous Substances Data: 1609341-02-7(Hazardous Substances Data)

Upstream product

• 1609082-35-0 ethyl 8-hydroxy-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylate 
• 1609082-34-9 ethyl 8-(benzyloxy)-2,6-dimethylimidazo[1,2-a] pyridine-3-carboxylate 
• 1609082-33-8 ethyl 8-(benzyloxy)-6-bromo-2-methylimidazo[1,2-a]pyridine-3-carboxylate 
• 754230-78-9 3-(benzyloxy)-5-bromopyridine-2-amine 
• 24016-03-3 2-amino-3-benzyloxypyridine 
• 23199-56-6 2,2,2-trifluoroethyltrichloromethanesulfonate 
• 1609340-84-2 N-(2-amino-2-methylpropyl)-8-[(2,6-difluorobenzyl)oxy]-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxamide 
• 85118-00-9 2,6-Difluorobenzyl bromide 
• 1609082-37-2 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylic acid 
• 1609082-36-1 ethyl 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethylimidazo[1,2-a]pyridine-3-carboxylate 

Relevant articles and documents

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.